Valuation: Tsumura & Co.

Market Cap 287B 1.83B 1.59B 1.5B 1.37B 2.56B 175B 2.57B 18.02B 6.96B 89.15B 6.86B 6.71B P/E 2027 *
11.1x
P/E 2028 * 10.8x
Enterprise Value 383B 2.44B 2.13B 2.01B 1.82B 3.42B 234B 3.43B 24.05B 9.28B 119B 9.16B 8.96B EV / Sales 2027 *
1.78x
EV / Sales 2028 * 1.86x
Free-Float
90.5%
Yield 2027 *
4.11%
Yield 2028 * 4.48%
1 day-0.98%
1 week+3.52%
Current month+1.75%
1 month+3.41%
3 months+3.30%
6 months+2.26%
Current year-5.62%
1 week 3,716
Extreme 3716
3,888
1 month 3,642
Extreme 3642
3,888
Current year 3,513
Extreme 3513
4,403
1 year 3,444
Extreme 3444
4,403
3 years 2,580
Extreme 2580
5,138
5 years 2,536
Extreme 2536
5,138
10 years 2,189
Extreme 2189
5,138
Manager TitleAgeSince
Chief Executive Officer 63 2019-05-31
Director of Finance/CFO - -
Chief Operating Officer 56 2022-03-31
Director TitleAgeSince
Director/Board Member 63 2011-05-31
Director/Board Member 77 2018-05-31
Director/Board Member 70 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%+3.52%+3.14%+38.27% 1.83B
+0.04%+3.34%+53.32%+100.52% 1,028B
-0.09%+1.66%+53.24%+66.45% 651B
-0.02%+2.66%+18.65%+71.97% 466B
-1.22%+3.66%+34.59%+38.81% 346B
-0.79%+2.73%+17.73%+25.11% 266B
+0.58%+6.76%+10.58%+17.75% 259B
+1.55%+2.20%+35.12%+45.91% 208B
+0.79%+1.84%-27.55%-56.48% 191B
-0.52%+4.45%+31.57%+98.11% 186B
Average -0.07%+3.28%+23.04%+44.64% 360.36B
Weighted average by Cap. -0.04%+3.09%+34.83%+61.59%

Financials

2027 *2028 *
Net sales 215B 1.37B 1.19B 1.13B 1.02B 1.91B 131B 1.92B 13.48B 5.2B 66.68B 5.13B 5.02B 228B 1.45B 1.27B 1.2B 1.09B 2.04B 139B 2.04B 14.33B 5.53B 70.9B 5.46B 5.34B
Net income 25.77B 164M 143M 135M 123M 230M 15.75B 231M 1.62B 625M 8.01B 617M 603M 26.61B 169M 148M 140M 127M 237M 16.26B 238M 1.67B 645M 8.27B 637M 623M
Net Debt 95.92B 611M 533M 503M 457M 856M 58.63B 860M 6.03B 2.33B 29.81B 2.3B 2.24B 137B 871M 760M 717M 651M 1.22B 83.6B 1.23B 8.59B 3.32B 42.51B 3.27B 3.2B
Logo Tsumura & Co.
Tsumura & Co is a Japan-based company mainly engaged in manufacturing and sales of prescription drugs and over-the-counter drugs. The Company operates the Pharmaceuticals segment. In Japan, the Company conducts the manufacturing, sales, transportation and storage of prescription drugs and over-the-counter drugs, and cultivation, procurement, selection, processing and storage of raw medicinal herbs. In China, the Company is engaged in regional management, business management, production and sales of herbal extract powders, cultivation, procurement, selection, processing and storage of herbal ingredients, and sales of pharmaceuticals and food products. In Laos, the Company is engaged in cultivation, procurement, selection, processing and storage of herbal ingredients. In the United States, the Company is engaged in pharmaceutical development business.
Employees
4,923
Date Price Change Volume
26-09-18 JP¥3,848.00 -0.98% 1,343,300
26-09-17 JP¥3,886.00 +2.21% 800,200
26-09-16 JP¥3,802.00 +0.96% 332,000
26-09-15 JP¥3,766.00 -0.61% 511,900
26-09-14 JP¥3,789.00 +1.94% 508,100
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
3,848.00JPY
Average target price
4,292.50JPY
Spread / Average Target
+11.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4540 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!